In contrast, a decrease in the expression of PPARGC1A has been observed in experimental animal models of CS-induced COPD, e.g., in mice instilled with CSE [116] or in mice instilled with LPS and CS [117]. Here, PPARGC1A is linked to chronic obstructive pulmonary disease.